Telbivudine - Novartis
At a glance
- Drug Originator Centre National de la Recherche Scientifique; Idenix Pharmaceuticals; University of Montpellier II
- Drug Licenced by Novartis
- Drug Class Antivirals; Nucleosides; Pyrimidines; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
- USA Patent Applicants NOVARTIS
- USA Patents 7
- NDAs 2
- Patent Applications 3,060
Table of Contents
Disclaimer